Skip to main content

UBS Group AG

Position in ALZN — Alzamend Neuro, Inc.

CIK 1610520 ZURICH, V8

Position in ALZN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,822
-$1,951 QoQ
Shares Held
2,352
-47.8% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 12 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALZN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. ALZN ranks #492 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALZN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,822 2,352
2026-03-31 $4,773 4,504
2025-12-31 $44,711 24,567
2025-09-30 $4,938 2,075
2025-06-30 $2,624 902
2024-12-31 $951 820
2024-06-30 $2,022 5,132
2023-12-31 $1,699 1,909
2023-09-30 $1,878 7,927
2023-06-30 $132 259
2023-03-31 $1,263 2,973
2022-12-31 $5,174 9,159
2022-09-30 $21,899 18,403
2022-06-30 $17,523 20,282
2022-03-31 $19,773 16,076
2021-12-31 $4,894 2,576
2021-09-30 $8,368 2,717
2021-06-30 $23,519 2,691